康方生物-B(09926)单抗及双抗共舞,肿瘤与免疫齐飞

国金证券
Dec 04, 2020

基本结论国际领先的创新型生物医药公司。2012年在中国中山成立,主要从事生物制药产品研发、技术转让及咨询服务。已组建了具有国际先进水平的高端生物药开发、产业化人才团队,包括多位海归专家;通过自身先进的ACE平台持续快速地创新生产高质量候选药物,研发管线覆盖抗肿瘤、自身免疫疾病等多个领域,拥有在研项目20多项,其中处于临床研究阶段产品11项。在研管线涵盖肿瘤、免疫领域多款未来重磅品种。抗肿瘤领域,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10